Literature DB >> 1223660

Inhibition of ADH release in the rat by narcotic antagonists.

M Miller.   

Abstract

The diuretic action of two new narcotic antagonists, oxilorphan and butorphanol, was studied in rats heterozygous for hereditary hypothalmic diabetes insipidus. Both drugs caused a prompt increase in urine volume and a decrease in urine osmolality with an associated decrease in urinary ADH excretion. The effects appeared to be dose related and of short duration. Tolerance to butorphanol administration was evident on repeated daily injections. The diuretic effect was not associated with alternation in creatinine excretion, but butorphanol resulted in decreased osmolal, sodium and potassium excretion. Butorphanol prevented the expected rise in urine osmolality and ADH excretion due to 31 h of dehydration. Oxilorphan did not interfere with the ability of administered ADH to cause an antidiuresis. The data indicate that these narcotic antagonists cause a diuresis by inhibiting ADH release from the neurohypophysis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1223660     DOI: 10.1159/000122444

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  9 in total

1.  Studies on the adrenomedullary dependence of kappa-opioid agonist-induced diuresis in conscious rats.

Authors:  K R Borkowski
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

2.  Kappa-opioid-receptor agonists modulate the renal excretion of water and electrolytes in anaesthetized rats.

Authors:  N Ashton; R J Balment; T P Blackburn
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

3.  Kappa-opioid-induced changes in renal water and electrolyte management and endocrine secretion.

Authors:  N Ashton; R J Balment; T P Blackburn
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

Review 4.  Butorphanol: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-12       Impact factor: 9.546

5.  Ingestive behaviour of the pigeon: stereoselective influence of the opiate agonist levorphanol and its antagonism by naloxone.

Authors:  P Deviche; G Schepers
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  The effects of N-(cyclopropylmethyl)-19-isopentylnororvinol (M320), a potent agonist at kappa- and mu-opiate receptors, on urine excretion of rats.

Authors:  J M Abrahams; A L Boura; R G Evans; C I Johnston; J E Olley
Journal:  Br J Pharmacol       Date:  1986-12       Impact factor: 8.739

7.  Influence of asimadoline, a new kappa-opioid receptor agonist, on tubular water absorption and vasopressin secretion in man.

Authors:  H J Kramer; W Uhl; B Ladstetter; A Bäcker
Journal:  Br J Clin Pharmacol       Date:  2000-09       Impact factor: 4.335

8.  On the mechanisms of kappa-opioid-induced diuresis.

Authors:  T P Blackburn; K R Borkowski; J Friend; M J Rance
Journal:  Br J Pharmacol       Date:  1986-11       Impact factor: 8.739

9.  Evidence for a role of opioid peptides in the release of arginine vasopressin in the conscious rat.

Authors:  S Ishikawa; R W Schrier
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.